SEC Company Response from AYTU BIOPHARMA, INC (AYTU) (CIK 0001385818) (AYTU) — May 8, 2007
AYTU BIOPHARMA, INC (AYTU) (CIK 0001385818)
Date: May 8, 2007 · CIK: 0001385818 · Accession: 0001079974-07-000296
AI Filing Summary & Sentiment
File numbers found in text: 333-139933
Show Raw Text
CORRESP
1
filename1.htm
Request for Acceleration
Rosewind
Corporation
16200
WCR 18 E
Loveland,
CO 80537
970-635-0346
May
8,
2007
Mr.
William Bennett, Staff Attorney
U.S.
Securities and Exchange
Commission
100
F
Street, N. E.
Washington,
D.C. 20549
VIA
FAX:
202-772-9205 and EDGAR
Re: Rosewind
Corporation
Form
SB-2
Registration Statement
File
No.
333-139933
Ladies
and Gentlemen;
This
request for acceleration hereby supersedes the request for acceleration
previously filed on May 3rd. At this time, on behalf of the Company, we
hereby request acceleration of the effective date of the Registration Statement
pursuant to Rule 461 to Thursday, May 10, 2007 at 3 PM, Washington, D.C.
local
time, or as soon as practicable thereafter. In connection with this request,
we
represent the following:
Should
the Commission or the staff, acting pursuant to delegated authority, declare
the
filing effective, it does not foreclose the Commission from taking any action
with respect to the filing;
The
action of the Commission or the staff, acting pursuant to delegated authority,
in declaring the filing effective, does not relieve the Company from its full
responsibility for the adequacy and accuracy of the disclosure in the filing;
and
The
Company may not assert staff comments and the declaration of effectiveness
as a
defense in any proceeding initiated by the Commission or any person under the
federal securities laws of the United States.
We
confirm that we are aware of our responsibilities under the Securities Act
and
the Securities Exchange Act as they relate to the public offering of securities
specified in the Registration Statement. Further, we understand that request
for
acceleration is a confirmation of the fact that we are aware of our
responsibilities under the federal securities laws. If you have any additional
questions, do not hesitate to contact me, James Wiegand at (970)635-0346. For
accounting comments, please contact Rachel Boulds, HJ & Associates at
801-328-4408.
Rosewind
Corporation
/s/
James Wiegand
James
Wiegand, President